Reata Pharmaceuticals Inc (NASDAQ:RETA)
| 21.70 BATS BZX Real-Time Price As of 10:25am ET |  -2.35 / -9.77%Today’s Change | 20.24 Today|||52-Week Range 125.27 | -17.71% Year-to-Date |
Latest RETA News | Press Releases
| Reata Pharmaceuticals, Inc. (RETA) Reports Q2 Loss, Lags Revenue Estimates Aug 08 / Zacks.com - Paid Partner Content | Gilead Sciences (GILD) Beats Q2 Earnings and Revenue Estimates Aug 02 / Zacks.com - Paid Partner Content |
| Provention Bio, Inc. (PRVB) Reports Q2 Loss, Lags Revenue Estimates Aug 04 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 24.05 |
| Today’s open | 23.77 |
| Day’s range | 21.16 - 23.77 |
| Volume | 19,112 |
| Average volume (3 months) | 486,180 |
| Market cap | $1.3B |
Data as of 10:25am ET, 08/09/2022
Growth & Valuation
| Earnings growth (last year) | -11.40% |
| Earnings growth (this year) | -4.17% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +27.40% |
| P/E ratio | NM |
| Price/Sales | 83.36 |
| Price/Book | 7.03 |
Competitors
Data as of 10:25am ET, 08/09/2022
Financials
| Next reporting date | November 14, 2022 |
| EPS forecast (this quarter) | -$2.21 |
| Annual revenue (last year) | $11.5M |
| Annual profit (last year) | -$297.4M |
| Net profit margin | -2,588.22% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Plano, Texas |
Forecasts
